pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 9 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,347
  • earnings286
  • pdufa275
  • phase 2 completion166
  • phase 1 completion71
  • phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07481981: A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

    Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07594730: Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems

    Sponsor: New York State Psychiatric Institute. Phase: NA. Conditions: Depression Disorders, ADHD, Substance Abuse, Social Stigma, Help-Seeking Behavior, Caregiver Burden

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02361528: GM-CSF to Decrease ICU Acquired Infections

    Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Septic Shock, Severe Sepsis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07322328: Effect of Hypo-pressive Exercises and Pelvic Floor Muscle Training in Postpartum Stress Urinary Incontinence Women

    Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Stress Urinary Incontinence (SUI), Stress Urinary Incontinence in Women

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05005728: XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

    Sponsor: Xencor, Inc.. Phase: PHASE2. Conditions: Metastatic Castration-Resistant Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04454528: BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy

    Sponsor: Abramson Cancer Center at Penn Medicine. Phase: PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07537465: Mirror Therapy for Complex Regional Pain Syndrome in Stroke Patients

    Sponsor: Başakşehir Çam & Sakura City Hospital. Phase: NA. Conditions: Stroke, Complex Regional Pain Syndrome I (CRPS I), Mirror Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07156565: Actinium Therapy for Late-stage Aggressive Sarcomas

    Sponsor: Ratio Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Soft Tissue Sarcoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07563842: Updated Abdominal Compartment Society Consensus Definitions

    Sponsor: Medical University of Lublin. Phase: . Conditions: Abdominal Hypertension, Abdominal Compartment Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07446686: Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

    Sponsor: Guizhou Provincial People's Hospital. Phase: EARLY_PHASE1. Conditions: Breast Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03684486: Rehabilitation by Effort for Patients With Advanced Bronchial Cancer

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Bronchial Cancer, Malignant Mesothelioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04643041: Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer

    Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Rectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07458841: Nurse-Led Discharge Program and Primary Care Outcomes: A Proof-of-concept Cluster Randomized Controlled Trial

    Sponsor: The University of Hong Kong. Phase: NA. Conditions: Primary Healthcare

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05746273: Depressed Mood Improvement Through Nicotine Dosing 3

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Depressive Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06715241: A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS

    Sponsor: ARCAGY/ GINECO GROUP. Phase: PHASE2. Conditions: LOCALLY ADVANCED CERVICAL CANCERS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07465341: Michigan Weight Navigation Program (MiWeigh) Study

    Sponsor: University of Michigan. Phase: NA. Conditions: Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07429305: Combined Tibial Nerve Stimulation and Standing for People With SCI

    Sponsor: University of British Columbia. Phase: NA. Conditions: Spinal Cord Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07511894: Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer

    Sponsor: Nanfang Hospital, Southern Medical University. Phase: PHASE2. Conditions: Gastric Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05358951: Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)

    Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Insomnia, Insomnia Due to Medical Condition, Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07476729: International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

    Sponsor: Charite University, Berlin, Germany. Phase: PHASE3. Conditions: B-Cell Acute Lymphoblastic Leukaemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05600829: A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity

    Sponsor: University of Calgary. Phase: NA. Conditions: Atrial Fibrillation, Obesity

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06737237: Cervical Plexus Versus Infiltration for Clavicular Operations (CERPICO)

    Sponsor: Naval Medical Center Camp Lejeune. Phase: NA. Conditions: Clavicle Surgery, Clavicle Fracture, Acromioclavicular Joint, Coracoclavicular Ligament

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03870672: rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke

    Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Stroke, Hemiplegia, Cerebrovascular Accident (CVA), Hemiparesis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06126172: Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05310695: A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

    Sponsor: Nordlandssykehuset HF. Phase: NA. Conditions: Musculoskeletal Disorder, Anxiety Disorders, Depression, Fatigue, Pain, Occupational Exposure, Work Related Stress, Workplace Bullying, Employment, Sickness Absence, Return to Work

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07429695: Eye-Tracking Interactive Agent in Non-verbal ICU Patients

    Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Eye Tracking, ICU, Communication Barriers, Non-Verbal Communication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07102095: A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose

    Sponsor: Bayer. Phase: PHASE1. Conditions: Hepatic Insufficiency, Liver Diseases, Pharmacokinetics, Drug Metabolism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442877: A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

    Sponsor: Haisco Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Postoperative Pain Management

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT05973877: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07355075: A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

    Sponsor: Turn Therapeutics. Phase: PHASE2. Conditions: Eczema Atopic Dermatitis, Eczema, Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07491757: Determining the Effects of Training on Nursing Students Using Two Different Methods for Maintaining Fluid and Electrolyte Balance in a Child Trapped Under a Collapse

    Sponsor: Selcuk University. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07390357: Effect of Photobiomodulation on Orthodontic Tooth Movement

    Sponsor: Wroclaw Medical University. Phase: NA. Conditions: Class II Malocclusion, Orthodontic Tooth Movement

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06359301: H-34 DELTA Revision Cup

    Sponsor: Limacorporate S.p.a. Phase: . Conditions: Hip, Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07681401: Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood

    Sponsor: University of Utah. Phase: NA. Conditions: Family Caregivers, Dementia, Financial Wellbeing, Financial Coaching

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05575401: Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy

    Sponsor: Loma Linda University. Phase: NA. Conditions: Sleep-Disordered Breathing, Sleep Apnea Syndromes in Children, Sleep Apnea, Obstructive, Tonsillitis, Tonsillar Hypertrophy, Tonsil Stone, Tonsil Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05423301: Global Physiotherapy in ICU Patients With High Risk Extubation Failure

    Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Acute Respiratory Failure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07218601: Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06166901: Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)

    Sponsor: Alcon Research. Phase: NA. Conditions: Aphakia, Astigmatism, Presbyopia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07310212: Evaluation of Postoperative Pain and Success Rate Between Lateral Condensation and Warm Vertical Obturation Techniques

    Sponsor: University of Jordan. Phase: NA. Conditions: Necrotic Pulp, Asymptomatic Apical Periodontitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04069312: Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

    Sponsor: Johns Hopkins University. Phase: PHASE4. Conditions: Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07185919: A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

    Sponsor: Ipsen. Phase: . Conditions: Progressive Familial Intrahepatic Cholestasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06528665: Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects

    Sponsor: Corium Innovations, Inc.. Phase: . Conditions: Multiple Sclerosis, Ulcerative Colitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07545265: SKB565 for Injection in Advanced Solid Tumors

    Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04506567: Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05259527: Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy

    Sponsor: Virginia Commonwealth University. Phase: PHASE2. Conditions: Neuropathic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03495427: PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: PHASE2. Conditions: Prostate Cancer, Recurrent Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06043427: Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

    Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Gastroesophageal Adenocarcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05541627: A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

    Sponsor: AskBio France, SAS, a subsidiary of AskBio Inc.. Phase: PHASE1. Conditions: Huntington Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05866861: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus

    Sponsor: Cugene Inc.. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, SLE (Systemic Lupus), Autoimmune

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04899661: A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia

    Sponsor: Bayer. Phase: . Conditions: Renal Anemia

    full page →ctgov ↗
    ← prev
    page 76 of 104
    next →